{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:07:23Z","timestamp":1793236043062,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejim.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T20:37:30Z","timestamp":1651869450000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Acute kidney injury associated with non-steroidal anti-inflammatory drugs"],"prefix":"10.1016","volume":"101","author":[{"given":"Nattawat","family":"Klomjit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4817-9404","authenticated-orcid":false,"given":"Patompong","family":"Ungprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ejim.2022.05.003_bib0001","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2165\/00003495-200464230-00001","article-title":"NSAID-related psychiatric adverse events: who is at risk?","volume":"64","author":"Onder","year":"2004","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.ejim.2022.05.003_bib0002","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"Faseb j"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0004","doi-asserted-by":"crossref","first-page":"400","DOI":"10.21037\/atm-20-3826","article-title":"The clinicopathological features of drug-induced acute kidney injury-a single-center retrospective analysis","volume":"9","author":"Cui","year":"2021","journal-title":"Ann Transl Med"},{"issue":"7","key":"10.1016\/j.ejim.2022.05.003_bib0005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/j.1552-4604.1991.tb03743.x","article-title":"Nonsteroidal anti-inflammatory drugs: effects on kidney function","volume":"31","author":"Whelton","year":"1991","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0006","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1053\/j.ajkd.2020.03.023","article-title":"NSAIDs in CKD: are they safe?","volume":"76","author":"Baker","year":"2020","journal-title":"American J Kidney Dis"},{"issue":"11","key":"10.1016\/j.ejim.2022.05.003_bib0007","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1001\/jamainternmed.2018.4273","article-title":"Frequency and associations of prescription nonsteroidal anti-inflammatory drug use among patients with a musculoskeletal disorder and hypertension, heart failure, or chronic kidney disease","volume":"178","author":"Bouck","year":"2018","journal-title":"JAMA Internal Med"},{"issue":"9","key":"10.1016\/j.ejim.2022.05.003_bib0008","doi-asserted-by":"crossref","first-page":"e14405","DOI":"10.1111\/ctr.14405","article-title":"NSAID prescriptions in kidney transplant recipients","volume":"35","author":"Jeong","year":"2021","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0009","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1357-2725(98)00152-6","article-title":"Cyclooxygenase-1 and -2 isoenzymes","volume":"31","author":"Hla","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-199600525-00004","article-title":"The mechanisms of action of NSAIDs in analgesia","volume":"52","author":"Cashman","year":"1996","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0011","first-page":"655","article-title":"Selective COX-2 inhibitors: a review of their structure-activity relationships","volume":"10","author":"Zarghi","year":"2011","journal-title":"Iran J Pharm Res"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0012","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/bega.2001.0236","article-title":"COX-1 and COX-2 inhibitors","volume":"15","author":"Hawkey","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0013","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ki.1981.78","article-title":"Metabolism of prostaglandins in the kidney","volume":"19","author":"Sun","year":"1981","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0014","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1590\/2175-8239-jbn-2018-0107","article-title":"Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs","volume":"41","author":"Lucas","year":"2019","journal-title":"J Bras Nefrol"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0015","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","article-title":"Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction","volume":"94","author":"Harris","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2022.05.003_bib0016","first-page":"27","article-title":"Prostaglandin I2 and the kidney","volume":"82 Spec No 4","author":"Dunn","year":"1989","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0017","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1998.00213.x","article-title":"Localization of the prostacyclin receptor in human kidney","volume":"54","author":"K\u00f6mhoff","year":"1998","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0018","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00424-018-2229-6","article-title":"Endothelial prostacyclin protects the kidney from ischemia-reperfusion injury","volume":"471","author":"Cao","year":"2019","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ejim.2022.05.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/147894","article-title":"Role of COX-2\/mPGES-1\/prostaglandin E2 cascade in kidney injury","volume":"2015","author":"Jia","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ki.1992.217","article-title":"Thromboxane synthesis and action within the kidney","volume":"41","author":"Remuzzi","year":"1992","journal-title":"Kidney Int"},{"issue":"41","key":"10.1016\/j.ejim.2022.05.003_bib0021","doi-asserted-by":"crossref","first-page":"35028","DOI":"10.1074\/jbc.M505852200","article-title":"Characterization of a rabbit kidney prostaglandin F(2{alpha}) receptor exhibiting G(i)-restricted signaling that inhibits water absorption in the collecting duct","volume":"280","author":"H\u00e9bert","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0022","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0022-3565(25)11035-5","article-title":"Wong PY. Renal response to 9 alpha, 11 beta-prostaglandin F2 in the rat","volume":"243","author":"Stier CT","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0023","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.00287.2020","article-title":"PGF(2\u03b1) stimulates the 10-pS Cl(-) channel and thiazide-sensitive Na(+)-Cl(-) cotransporter in the distal convoluted tubule","volume":"319","author":"Wang","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ejim.2022.05.003_bib0024","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.pa.33.040193.002251","article-title":"Renal toxicity of the nonsteroidal anti-inflammatory drugs","volume":"33","author":"Murray","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ejim.2022.05.003_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2019.00520","article-title":"The invisible threat of non-steroidal anti-inflammatory drugs for kidneys","volume":"7","author":"Clav\u00e9","year":"2019","journal-title":"Frontiers in Pediatrics"},{"issue":"18","key":"10.1016\/j.ejim.2022.05.003_bib0026","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1161\/01.CIR.0000034733.93020.BC","article-title":"Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction","volume":"106","author":"Yokoyama","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2022.05.003_bib0027","first-page":"155","article-title":"Effects of NSAIDs on the kidney","volume":"49","author":"Murray","year":"1997","journal-title":"Prog Drug Res"},{"issue":"9","key":"10.1016\/j.ejim.2022.05.003_bib0028","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with nonsteroidal antiinflammatory drugs","volume":"310","author":"Clive","year":"1984","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0029","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00431-003-1392-7","article-title":"Acute renal failure after treatment with non-steroidal anti-inflammatory drugs","volume":"163","author":"Ulinski","year":"2004","journal-title":"Eur J Pediatr"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM198402093100603","article-title":"Prostaglandins in Severe Congestive Heart Failure","volume":"310","author":"Dzau","year":"1984","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejim.2022.05.003_bib0031","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ndt\/gfz062","article-title":"Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study","volume":"34","author":"Nash","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0032","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12882-017-0673-8","article-title":"Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0033","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/pds.5385","article-title":"Nonsteroidal anti-inflammatory drugs associated acute kidney injury in hospitalized children: a systematic review and meta-analysis","volume":"31","author":"Gong","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ejim.2022.05.003_bib0034","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpeds.2017.06.045","article-title":"Subclinical kidney injury in children receiving nonsteroidal anti-inflammatory drugs after cardiac surgery","volume":"189","author":"Nehus","year":"2017","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.ejim.2022.05.003_bib0035","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1097\/TP.0000000000002689","article-title":"Long-term assessment of NSAID prescriptions and potential nephrotoxicity risk in adult kidney transplant recipients","volume":"103","author":"Chiasson","year":"2019","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122899","article-title":"Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study","volume":"10","author":"Ingrasciotta","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0037","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejim.2015.03.008","article-title":"Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies","volume":"26","author":"Ungprasert","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2022.05.003_bib0038","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/IJNRD.S121698","article-title":"Selective cyclooxygenase-2 inhibitor use and progression of renal function in patients with chronic kidney disease: a single-center retrospective cohort study","volume":"9","author":"Kaewput","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0039","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2015.101","article-title":"Combined use of nonsteroidal anti-inflammatory drugs with diuretics and\/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury","volume":"88","author":"Dreischulte","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2022.05.003_bib0040","doi-asserted-by":"crossref","first-page":"e8525","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2022.05.003_bib0041","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2016.07.011","article-title":"Mechanisms of triple whammy acute kidney injury","volume":"167","author":"Prieto-Garc\u00eda","year":"2016","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0042","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1248\/bpb.b17-00547","article-title":"Association between concomitant use of acyclovir or valacyclovir with NSAIDs and an increased risk of acute kidney injury: data mining of FDA adverse event reporting system","volume":"41","author":"Yue","year":"2018","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0043","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5414\/CNP71567","article-title":"Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction","volume":"71","author":"Morelle","year":"2009","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0044","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-199717050-00001","article-title":"NSAIDs and increased blood pressure. What is the clinical significance?","volume":"17","author":"Johnson","year":"1997","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1993.00410040045007","article-title":"A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure","volume":"153","author":"Pope","year":"1993","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0046","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2261-12-93","article-title":"Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension","volume":"12","author":"Aljadhey","year":"2012","journal-title":"BMC Cardiovascular Disorders"},{"issue":"44","key":"10.1016\/j.ejim.2022.05.003_bib0047","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1093\/eurheartj\/ehx508","volume":"38","author":"Ruschitzka","year":"2017","journal-title":"Eur Heart J"},{"issue":"6a","key":"10.1016\/j.ejim.2022.05.003_bib0048","doi-asserted-by":"crossref","first-page":"18d","DOI":"10.1016\/S0002-9149(02)02233-6","article-title":"Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema","volume":"89","author":"Frishman","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2022.05.003_bib0049","first-page":"116","volume":"5","author":"Kim","year":"2007"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.HYP.21.6.875","article-title":"Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension","volume":"21","author":"Ferri","year":"1993","journal-title":"Hypertension"},{"issue":"33","key":"10.1016\/j.ejim.2022.05.003_bib0051","first-page":"1521","article-title":"[Hyponatremia caused by thiazide diuretics: be aware of drug combinations which enhance this effect]","volume":"146","author":"Kalksma","year":"2002","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0052","first-page":"236","article-title":"Acute hyponatremia after a religious fast","volume":"7","author":"Rosen","year":"2021","journal-title":"AACE Clin Case Rep"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0053","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03401295","article-title":"Severe water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin: a case report and review of the literature","volume":"12","author":"Verrua","year":"2013","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.ejim.2022.05.003_bib0054","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psychres.2019.05.009","article-title":"Meloxicam-desmopressin drug-drug interaction producing hyponatremia","volume":"279","author":"Bojdani","year":"2019","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsem-2018-000364","article-title":"Serum sodium changes in marathon participants who use NSAIDs","volume":"4","author":"Whatmough","year":"2018","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0056","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/JSM.0000000000000144","article-title":"Incidence of exercise-associated hyponatremia and its association with nonosmotic stimuli of arginine vasopressin in the GNW100s ultra-endurance marathon","volume":"25","author":"Cairns","year":"2015","journal-title":"Clin J Sport Med"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0057","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.0954-6820.1987.tb01272.x","article-title":"Water intoxication associated with non-steroidal anti-inflammatory drug therapy","volume":"221","author":"Petersson","year":"1987","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ejim.2022.05.003_bib0058","first-page":"5","article-title":"Syndrome of inappropriate antidiuretic hormone secretion associated with prolonged keterolac use","volume":"2","author":"Lim","year":"2014","journal-title":"Clin Nephrol Case Stud"},{"key":"10.1016\/j.ejim.2022.05.003_bib0059","article-title":"Syndrome of inappropriate antidiuretic hormone secretion and Ibuprofen, a rare association to be considered: role of tolvaptan","volume":"2013","author":"Artom","year":"2013","journal-title":"Case Rep Endocrinol"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.14283\/jfa.2019.18","article-title":"Drug-induced hyponatremia: NSAIDs, a neglected cause that should be considered","volume":"8","author":"Damanti","year":"2019","journal-title":"J Frailty Aging"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2012.09.002","article-title":"Life-threatening hyperkalemia after 2 days of ibuprofen","volume":"31","author":"Platts-Mills","year":"2013","journal-title":"Am J Emerg Med"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0062","first-page":"e15648","article-title":"Association between long-term use of non-steroidal anti-inflammatory drugs and hyperkalemia in diabetic patients","volume":"13","author":"Sahil","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0063","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ajkd.2012.02.328","article-title":"Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: a nested case-control study","volume":"60","author":"Lafrance","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0064","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000166578","article-title":"Ibuprofen-induced acute renal failure with acute tubular necrosis","volume":"2","author":"Fong","year":"1982","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ejim.2022.05.003_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/IJNRD.S212010","article-title":"NSAID associated bilateral renal infarctions: a case report","volume":"12","author":"Jeon","year":"2019","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0066","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s11255-011-9982-1","article-title":"Single-dose-dexketoprofen-induced acute kidney injury due to massive rhabdomyolysis","volume":"44","author":"Sav","year":"2012","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"10.1016\/j.ejim.2022.05.003_bib0067","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2010.89","article-title":"Acute interstitial nephritis","volume":"77","author":"Praga","year":"2010","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0068","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0002-9343(84)90849-0","article-title":"Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs. Immunologic characterization of the inflammatory infiltrate","volume":"76","author":"Bender","year":"1984","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0069","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","article-title":"Biopsy-proven acute interstitial nephritis, 1993-2011: a case series","volume":"64","author":"Muriithi","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.ejim.2022.05.003_bib0070","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","article-title":"Acute interstitial nephritis: clinical features and response to corticosteroid therapy","volume":"19","author":"Clarkson","year":"2004","journal-title":"Nephrol Dialysis Transplant"},{"issue":"9","key":"10.1016\/j.ejim.2022.05.003_bib0071","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2215\/CJN.08090719","article-title":"NSAIDs and nephrotic syndrome","volume":"14","author":"M\u00e9rida","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.ejim.2022.05.003_bib0072","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2215\/CJN.14331218","article-title":"Risk of nephrotic syndrome for non-steroidal anti-inflammatory drug users","volume":"14","author":"Bakhriansyah","year":"2019","journal-title":"Clin J American Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0073","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1053\/j.ajkd.2005.05.034","article-title":"Glomerular tip lesion associated with nonsteroidal anti-inflammatory drug-induced nephrotic syndrome","volume":"46","author":"Sekhon","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0074","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2013.03.045","article-title":"Membranous nephropathy and nonsteroidal anti-inflammatory agents","volume":"62","author":"Nawaz","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000183239","article-title":"Nephrotic syndrome associated with use of the nonsteroidal anti-inflammatory drugs. Case report and review of the literature","volume":"37","author":"Feinfeld","year":"1984","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0076","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0272-6386(85)80178-5","article-title":"Reversible renal failure and nephrotic syndrome without interstitial nephritis from zomepirac","volume":"6","author":"Bander","year":"1985","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0077","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/ajkd.2002.36349","article-title":"Nephrotic syndrome and interstitial nephritis associated with celecoxib","volume":"40","author":"Alper","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0078","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.ajkd.2020.02.444","article-title":"Successful treatment of patients with refractory PLA2R-associated membranous nephropathy with obinutuzumab: a report of 3 cases","volume":"76","author":"Klomjit","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2022.05.003_bib0079","article-title":"Secondary membranous nephropathy. A narrative review","volume":"7","author":"Moroni","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1681\/ASN.2020071082","article-title":"New 'antigens' in membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.003_bib0081","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.1996.03540060042033","article-title":"Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs","volume":"276","author":"Radford","year":"1996","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0082","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2337\/diab.3.2.124","article-title":"Renal papillary necrosis","volume":"3","author":"Aye","year":"1954","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0083","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1445-5994.1977.tb03681.x","article-title":"Analgesic abuse, renal papillary necrosis and concomitant drug intake","volume":"7","author":"Arnold","year":"1977","journal-title":"Aust N Z J Med"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0084","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0272-6386(12)80155-7","article-title":"Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic","volume":"24","author":"Segasothy","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.003_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4322\/acr.2013.042","article-title":"Renal papillary necrosis","volume":"3","author":"Geller","year":"2013","journal-title":"Autops Case Rep"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0086","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archinte.163.1.114","article-title":"Celecoxib-related renal papillary necrosis","volume":"163","author":"Akhund","year":"2003","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.ejim.2022.05.003_bib0087","first-page":"e16926","article-title":"Bilateral ureteral obstruction secondary to papillary necrosis from non-steroidal anti-inflammatory drug use in an adult patient","volume":"13","author":"Leung","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0088","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/10937409809524544","article-title":"Analgesic nephropathy in rodents","volume":"1","author":"Schnellmann","year":"1998","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"5637","key":"10.1016\/j.ejim.2022.05.003_bib0089","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bmj.1.5637.161","article-title":"Papillary necrosis in experimental analgesic nephropathy","volume":"1","author":"Saker","year":"1969","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.003_bib0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/01926230500222593","article-title":"Early pathophysiological features in canine renal papillary necrosis induced by nefiracetam","volume":"33","author":"Tsuchiya","year":"2005","journal-title":"Toxicol Pathol"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0091","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1681\/ASN.V62248","article-title":"Renal papillary necrosis\u2013a sixteen-year clinical experience","volume":"6","author":"Griffin","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0092","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00005792-199803000-00003","article-title":"A review of epidemiologic studies of nonnarcotic analgesics and chronic renal disease","volume":"77","author":"Delzell","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0093","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1523-1755.1998.00043.x","article-title":"Analgesic use and chronic renal failure: a critical review of the epidemiologic literature","volume":"54","author":"McLaughlin","year":"1998","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0094","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/fampra\/cms086","article-title":"Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review","volume":"30","author":"Nderitu","year":"2013","journal-title":"Fam Pract"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2006.02.015","article-title":"NSAID use and progression of chronic kidney disease","volume":"120","author":"Gooch","year":"2007","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0096","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/HYPERTENSIONAHA.114.05105","article-title":"Use of nonsteroidal anti-inflammatory drugs and risk of chronic kidney disease in subjects with hypertension: nationwide longitudinal cohort study","volume":"66","author":"Hsu","year":"2015","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0097","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/dme.12610","article-title":"Use of non-steroidal anti-inflammatory drugs and risk of chronic kidney disease in people with Type 2 diabetes mellitus, a nationwide longitudinal cohort study","volume":"32","author":"Tsai","year":"2015","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.003_bib0098","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s42506-018-0005-2","article-title":"Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study","volume":"94","author":"Abd ElHafeez","year":"2019","journal-title":"J Egypt Public Health Assoc"},{"issue":"10","key":"10.1016\/j.ejim.2022.05.003_bib0099","first-page":"1865","article-title":"A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study","volume":"24","author":"Liu","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.003_bib0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bjc.6690728","article-title":"Regular use of analgesics is a risk factor for renal cell carcinoma","volume":"81","author":"Gago-Dominguez","year":"1999","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.ejim.2022.05.003_bib0101","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.bjc.6600945","article-title":"Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study","volume":"88","author":"S\u00f8rensen","year":"2003","journal-title":"Br J Cancer"},{"issue":"16","key":"10.1016\/j.ejim.2022.05.003_bib0102","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archinternmed.2011.356","article-title":"Prospective evaluation of analgesic use and risk of renal cell cancer","volume":"171","author":"Cho","year":"2011","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.003_bib0103","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ijc.28093","article-title":"Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies","volume":"134","author":"Choueiri","year":"2014","journal-title":"Int J Cancer"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:35:52Z","timestamp":1760607352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":103,"alternative-id":["S0953620522001728"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.05.003","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute kidney injury associated with non-steroidal anti-inflammatory drugs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}